Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ostersjöstiftelsen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 6
Rounds per year 0.28
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
Summary

Ostersju00f6stiftelsen appeared to be the Corporate Investor, which was created in 1994. The main office of represented Corporate Investor is situated in the Huddinge. The venture was found in Europe in Sweden.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - Sweden. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Athera Biotechnologies, Dilafor, Modus Therapeutics.

The high activity for fund was in 2015. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Ostersju00f6stiftelsen, startups are often financed by Texas Venture Labs. The meaningful sponsors for the fund in investment in the same round are Rosetta Capital, Praktikerinvest, Midroc New Technology. In the next rounds fund is usually obtained by HealthCap.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anthony and Jeanne Pritzker Family Foundation -
ArrowPath Venture Partners California, Redwood Shores, United States
Bank of Shanghai -
Beasley Broadcast Group Florida, Naples, United States
BIG BOOSTER France, Lyon, Rhone-Alpes
Brillio California, Santa Clara, United States
Dominion Energy Technologies Richmond, United States, Virginia
First Data Merchant Services Corporation Atlanta, Georgia, United States
Licheng Touzi China, Huzhou, Zhejiang
MedioStream California, Los Altos, United States
Neowiz Seoul, Seoul-t'ukpyolsi, South Korea
Pole Innovation Metiers -
SAIC Venture Capital Las Vegas, Nevada, United States
Shengmei Guquan Touzi Jijin Guanli Beibei, China, Chongqing
Spark Telecom Brazil, São Paulo, Sao Paulo
Steel Pier Capital Advisors New York, New York, United States
VenturesLab Beijing, Beijing, China
Wermuth Asset Management Berlin, Berlin, Germany
Xinjiang Yuesheng Guquan Touzi Youxian Gongsi China, Ürümqi, Xinjiang

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ostersjöstiftelsen?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 3M
Rounds per year 0.28
Peak activity year 2017
Lead investments 0
Follow on index 0.25
Group Appearance index 0.88
Crunchbase icon

Content report

The following text will be sent to our editors: